Iterum Therapeutics plc

ITRM · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$25-$38-$44-$92
Dep. & Amort.$0$2$2$2
Deferred Tax$0$0$0$62
Stock-Based Comp.$0$1$22$4
Change in WC-$13$3$2-$0
Other Non-Cash$10-$6-$0$8
Operating Cash Flow-$27-$39-$18-$16
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$12-$41-$46-$67
Inv. Sales/Matur.$31$65$60$13
Other Inv. Act.$0$0$0-$0
Investing Cash Flow$18$23$14-$55
Financing Activities
Debt Repay.$0$0-$2-$7
Stock Issued$27$1$0$90
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$27$1-$2$83
Forex Effect-$0-$0-$0$0
Net Chg. in Cash$18-$15-$6$13
Supplemental Information
Beg. Cash$6$21$28$15
End Cash$24$6$21$28
Free Cash Flow-$27-$39-$19-$16